SCHEMBL7776147

SCHEMBL7776147

COc1ccccc1-c1nc(N)nc(O)c1I

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.57
ADORA1 P30542 2/20 0.56
HSP90AA1 P07900 2/20 0.50
HSP90AB1 P08238 1/20 0.50
ALDH1A1 P00352 5/20 0.49
GAA P10253 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.45
HPGD P15428 2/20 0.45
LRRK2 Q5S007 1/20 0.44
LMNA P02545 3/20 0.43
KDM4E B2RXH2 2/20 0.43
DHFR P00374 1/20 0.43
JAK2 O60674 1/20 0.42
MAPT P10636 3/20 0.41
DPP4 P27487 1/20 0.41
SLC2A1 P11166 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
PTPN1 P18031 1/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7777502 0.82 ADORA2A (0.57) ADORA2AADORA1HSP90AA1HSP90AB1ALDH1A1
SCHEMBL7776292 0.82 ADORA2A (0.57) ADORA2AADORA1HSP90AA1HSP90AB1ALDH1A1
SCHEMBL9133520 0.77 ADORA2A (0.54) ADORA2AADORA1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL4408835 0.73 ADORA2A (0.60) ADORA2AADORA1HSP90AA1HSP90AB1ALDH1A1
SCHEMBL7769989 0.73 ADORA2A (0.50) ADORA2AADORA1DHFRPOLB
SCHEMBL9131047 0.72 ADORA2A (0.41) ADORA2AADORA1SMN1; SMN2JAK2
SCHEMBL7777554 0.71 ADORA2A (0.58) ADORA2AADORA1HPGDKDM4EMAPT
SCHEMBL9134038 0.71 ADORA2A (0.49) ADORA2AADORA1DHFRPOLB
SCHEMBL27881848 0.71 ADORA2A (0.57) ADORA2AADORA1HSP90AA1HSP90AB1ALDH1A1
SCHEMBL3678540 0.71 HSP90AA1 (0.58) ADORA2AADORA1HSP90AA1HSP90AB1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2001505911-A 2001-05-08 JP claimed
EP-0948331-A2 METHOD FOR TREATING MULTIPLE SCLEROSIS PHARMACIA & UPJOHN COMPANY (US) 1999-10-13 EP claimed
WO-1998025596-A2 USE OF A 6-ARYL PYRIMIDINE COMPOUND FOR TREATING MULTIPLE SCLEROSIS PHARMACIA & UPJOHN COMPANY (US) 1998-06-18 WO claimed
US-5434157-A Active against herpes, hepatitis, papovavirus THE UPJOHN COMPANY (US) 1995-07-18 US claimed
EP-0948331-A2 METHOD FOR TREATING MULTIPLE SCLEROSIS PHARMACIA & UPJOHN COMPANY (US) 1999-10-13 EP disclosed
WO-1998025596-A2 USE OF A 6-ARYL PYRIMIDINE COMPOUND FOR TREATING MULTIPLE SCLEROSIS PHARMACIA & UPJOHN COMPANY (US) 1998-06-18 WO disclosed
US-5554617-A Method for treating cancer with 6-aryl pyrimidine compounds THE UPJOHN COMPANY (US) 1996-09-10 US disclosed
US-5434157-A Active against herpes, hepatitis, papovavirus THE UPJOHN COMPANY (US) 1995-07-18 US disclosed
US-5002951-A 2-amino-5-halo-4-pyrimidinol for bactericides and antiprotozoa agent THE UPJOHN COMPANY (US) 1991-03-26 US disclosed
US-4665077-A IMMUNOREGULATORY AGENTS THE UPJOHN COMPANY (US) 1987-05-12 US disclosed
US-4619933-A 6-aryl pyrimidines for treating aplastic anemia THE UPJOHN COMPANY (US) 1986-10-28 US disclosed
US-4543248-A Method for immunoregulation with 6-aryl pyrimidine compounds THE UPJOHN COMPANY (US) 1985-09-24 US disclosed
US-4507302-A Method for treating arthritis with 6-aryl pyrimidine compounds THE UPJOHN COMPANY (US) 1985-03-26 US disclosed